Pediapharm (CVE:PDP) Shares Up 1.7%

Pediapharm Inc. (CVE:PDPGet Free Report)’s share price rose 1.7% on Wednesday . The stock traded as high as C$0.31 and last traded at C$0.30. Approximately 26,000 shares were traded during mid-day trading, a decline of 74% from the average daily volume of 100,369 shares. The stock had previously closed at C$0.30.

Pediapharm Price Performance

The company has a current ratio of 1.12, a quick ratio of 0.71 and a debt-to-equity ratio of 186.87. The company has a 50 day moving average of C$0.30 and a 200-day moving average of C$0.30. The firm has a market capitalization of C$66.36 million and a P/E ratio of -4.11.

Pediapharm Company Profile

(Get Free Report)

Pediapharm Inc operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children.

Featured Stories

Receive News & Ratings for Pediapharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediapharm and related companies with MarketBeat.com's FREE daily email newsletter.